Diagnostics Pipeline: Labcorp Launches Holistic Medicine Service
The company is offering whole panels and more than 1,000 assays in total to support the new products
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
The company is offering whole panels and more than 1,000 assays in total to support the new products
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Using LIMS and no-code solutions can unlock opportunities for efficiency.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.